Cytokinetics (CYTK)

$45.74 2.7%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    7
  • Fundamental

    1
  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Cytokinetics, AI stock picks, stock alerts and much more.

Sign up

CYTK AI Stock Analysis

AI stock analysis for CYTK is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Cytokinetics (CYTK) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

CYTK Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Cytokinetics (CYTK), currently trading at $45.74, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About CYTK

LSE
  • Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases.

  • Symbol

    CYTK

  • Market

    NASDAQ

  • Industry

    Biotechnology

  • Market Cap

    5.4B

Similar Stocks

CPRX Catalyst Pharmaceuticals
CPRX
$22.78
0.5%
6
INO Inovio Pharmaceuticals
INO
$2.08
8.9%
4
MRNA Moderna
MRNA
$34.06
0.9%
4
AVXL Anavex Life Sciences
AVXL
$9.21
9.3%
6
BBIO BridgeBio Pharma
BBIO
$33.79
0.9%
7

CYTK Alternative Data

News Mentions

Sign up to access

Twitter Followers

Sign up to access

Facebook Engagement

Sign up to access

Youtube Subscribers

Sign up to access

LinkedIn Followers

Sign up to access

Job Postings

Sign up to access

LinkedIn Employees

Sign up to access

Web Traffic

Sign up to access

Business Outlook

Sign up to access

CYTK Financials

CYTK Key Metrics
  • Total Revenue

    $463K

  • Net Income

    -$160.5M

  • Earnings per Share

    -$1.36

  • Free cash flow

    -$104M

  • EBITDA

    -$138.2M

  • EBITDA Ratio

    -298.59

  • Total Assets

    $1.4B

CYTK 2-year Revenue & Income
CYTK 2-year Free Cash Flow

CYTK Technicals

CYTK SMA
CYTK RSI

FAQ

What's the current price of Cytokinetics (CYTK) Stock?
The price of an Cytokinetics (CYTK) share is $45.74.

What's the market cap of Cytokinetics?
The current market cap of Cytokinetics is 5.4B.

Should I buy or sell CYTK?
Cytokinetics shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Cytokinetics is better viewed as a hold or accumulate position while waiting for further developments.

Is Cytokinetics a good investment?
The current analysis of Cytokinetics' fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Cytokinetics' portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Cytokinetics (CYTK) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Cytokinetics stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Cytokinetics (CYTK) that investors often compare it to?
Cytokinetics (CYTK) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.

What is the forecast for Cytokinetics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Cytokinetics' stock price to be around $45.83 in 2026. Starting from the current price of $45.74, this represents a 0.2% change in price, indicating a neutral outlook for the stock.

How to buy Cytokinetics (CYTK) Stock?
Cytokinetics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Cytokinetics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.